4.6 Article

Benefits of Using CD45RA and CD28 to Investigate CD8 Subsets in Kidney Transplant Recipients

期刊

AMERICAN JOURNAL OF TRANSPLANTATION
卷 16, 期 3, 页码 999-1006

出版社

WILEY
DOI: 10.1111/ajt.13581

关键词

basic (laboratory) research; science; immunobiology; flow cytometry; monitoring: immune; T cell biology

资金

  1. ProGreffe Fondation
  2. ITMO Sante Publique
  3. National Research Agency via the Investment Into The Future program [ANR-10-IBHU-005]
  4. Nantes Metropole
  5. Pays de la Loire Region
  6. FP7 VISICORT project from European Union's Seventh Framework Programme for research, technological development and demonstration [602470]
  7. National Research Agency via investment of the future program [ANR-11-LABX-0016-01]

向作者/读者索取更多资源

The deleterious role of CD8 T cells in kidney graft outcome has regained interest over the years, and memory T cells are considered as one of the main hurdles to achieve transplantation success. Monitoring the CD8 immune response in transplant recipients involved a heterogeneous combination of markers, but the justification of their choice is rarely stated. Whereas the number of parameters is not an issue in phenotypic analysis, functional assays have to accommodate the cell number with the narrowing of the subset. The aim of the study was to investigate the similarities and differences of the subsets identified using three nomenclatures (CD45RA and CCR7/CD27/CD28) in kidney transplant recipients with stable graft function. We found that all three nomenclatures can identify naive and effector memory (EM) rheumatoid arthritis T cell CD8 with similar features. Whereas CM CD8 could only be documented using CCR7 and CD45RA, the characteristics of EM CD8 will differ according to the nomenclature. We found that the use of the CD45RA and CD28 gives the benefit of examining two EM populations at early and late differentiation states. This systematic comparison provides a cohesive layout of the advantages of using these nomenclature strategies in kidney transplant recipients to guide the choice of their use.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Urology & Nephrology

Terminally Differentiated Effector Memory CD8+ T Cells Identify Kidney Transplant Recipients at High Risk of Graft Failure

Lola Jacquemont, Gaelle Tilly, Michelle Yap, Tra-My Doan-Ngoc, Richard Danger, Pierrick Guerif, Florent Delbos, Bernard Martinet, Magali Giral, Yohann Foucher, Sophie Brouard, Nicolas Degauque

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Immunology

Transcriptional meta-analysis of regulatory B cells

Florian Dubois, Sophie Limou, Melanie Chesneau, Nicolas Degauque, Sophie Brouard, Richard Danger

EUROPEAN JOURNAL OF IMMUNOLOGY (2020)

Article Immunology

Efficient Expansion of Human Granzyme B-Expressing B Cells with Potent Regulatory Properties

Melanie Chesneau, Hoa Le Mai, Richard Danger, Sabine Le Bot, Thi-Van-Ha Nguyen, Josselin Bernard, Cyrielle Poullaouec, Pierrick Guerrif, Sophie Conchon, Magali Giral, Beatrice Charreau, Nicolas Degauque, Sophie Brouard

JOURNAL OF IMMUNOLOGY (2020)

Article Medicine, Research & Experimental

Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial

Benjamin Gaborit, Bernard Vanhove, Marie-Anne Vibet, Aurelie Le Thuaut, Karine Lacombe, Vincent Dubee, Florence Ader, Virginie Ferre, Eric Vicaut, Jeremie Orain, Morgane Le Bras, Anne Omnes, Laetitia Berly, Alexandra Jobert, Pascale Morineau-Le Houssine, Karine Botturi, Regis Josien, Laurent Flet, Nicolas Degauque, Sophie Brouard, Odile Duvaux, Alexandra Poinas, Francois Raffi

Summary: Early inhibition of SARS-CoV-2 entry and replication using polyclonal neutralizing antibodies shows promising therapeutic potential by providing immediate immunity and blocking viral infection in ACE-2-positive human cells. The study aims to determine the safety, optimal dose, and clinical benefits of XAV-19 in patients with COVID-19-induced moderate pneumonia, with the goal of potentially introducing it as a new therapeutic option in combination with antiviral and immunotherapies.

TRIALS (2021)

Review Biochemistry & Molecular Biology

Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection

Nicolas Degauque, Alain Haziot, Sophie Brouard, Nuala Mooney

Summary: In the inflammation and infection caused by SARS-CoV-2, endothelial cells play a crucial role in regulating the recruitment of immune cells and interacting with monocytes, T cells, and B cells. Endothelial cells function as an integrative and active platform for immune responses, providing opportunities for therapeutic intervention.

FASEB JOURNAL (2021)

Review Medicine, General & Internal

Pathogenesis of ANCA-associated vasculitides in 2021: An update

A. Neel, N. Degauque, S. Bruneau, C. Braudeau, M. Bucchia, A. Caristan, D. De Mornac, V Genin, A. Glemain, C. Oriot, M. Rimbert, S. Brouard, R. Josien, M. Hamidou

Summary: AAV is a group of rare systemic immune-mediated diseases characterized by small vessel necrotizing vasculitis and respiratory tract inflammation. Research in animal models and in humans has identified the roles of ANCA, neutrophils, T helper cells, B cells, complement activation, and other factors in the pathogenesis of AAV. New investigation tools may lead to a better understanding of the disease mechanisms and potential therapeutic targets.

REVUE DE MEDECINE INTERNE (2022)

Article Immunology

Teriflunomide Treatment of Multiple Sclerosis Selectively Modulates CD8 Memory T Cells

Gaelle Tilly, Marion Cadoux, Alexandra Garcia, Jeremy Morille, Sandrine Wiertlewski, Claire Pecqueur, Sophie Brouard, David Laplaud, Nicolas Degauque

Summary: The study found that 12 months of treatment with teriflunomide in patients with RRMS did not affect B cell or CD4 T cell compartments, but had a specific impact on CD8 T cells, including decreased proliferation and reduced production of inflammatory factors. DHODH inhibition also affected the migratory velocity of memory CD8 T cells.

FRONTIERS IN IMMUNOLOGY (2021)

Article Surgery

Peripheral blood immune cell profiling of acute corneal transplant rejection

Jesper Hjortdal, Matthew D. Griffin, Marion Cadoux, W. John Armitage, Max Bylesjo, Peadar Mac Gabhann, Conor C. Murphy, Uwe Pleyer, Derek Tole, Bertrand Vabres, Malcolm D. Walkinshaw, Pierre-Antoine Gourraud, Matilde Karakachoff, Sophie Brouard, Nicolas Degauque

Summary: This study investigated the acute rejection of corneal transplants and found that there were no activation signatures within the B cell and T cell repertoire at the time of diagnosis. However, in recipients of full-thickness corneal transplants, acute rejection was associated with differences in B cell maturity and regulatory CD4(+) T cell frequency compared to stable allografts.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Urology & Nephrology

Effector Memory?Expressing CD45RA (TEMRA) CD8+ T Cells from Kidney Transplant Recipients Exhibit Enhanced Purinergic P2X4 Receptor?Dependent Proinflammatory and Migratory Responses

Tra-My Doan Ngoc, Gaelle Tilly, Richard Danger, Orianne Bonizec, Christophe Masset, Pierrick Guerif, Sarah Bruneau, Alexandre Glemain, Jean Harb, Marion Cadoux, Anais Vivet, Hoa Le Mai, Alexandra Garcia, David Laplaud, Roland Liblau, Magali Giral, Stephanie Blandin, Magalie Feyeux, Laurence Dubreuil, Claire Pecqueur, Matthew Cyr, Weiming Ni, Sophie Brouard, Nicolas Degauque

Summary: Our study reveals that humoral rejection of kidney transplants is associated with the accumulation of TEMRA CD8(+) T cells in blood and kidney graft biopsies. TEMRA CD8(+) T cells from kidney transplant recipients show enhanced migratory properties compared to EM CD8(+) T cells, with increased adhesion to activated endothelium and transmigration in response to CXCL12 chemokine. Furthermore, IL-15 stimulation promotes the migration of TEMRA and EM CD8(+) T cells induced by CXCL12 and enhances the generation of functional PSGL1, which interacts with P-selectin and facilitates adhesion to activated endothelium. Notably, inhibiting the migration of TEMRA CD8(+) T cells from kidney transplant recipients by targeting VLA-4 or LFA-1 suggests the potential therapeutic benefit of targeting these cells in transplant recipients.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Medicine, General & Internal

Antibody-mediated allograft rejection is associated with an increase in peripheral differentiated CD28-CD8

Hoa Le Mai, Nicolas Degauque, Sabine Le Bot, Marie Rimbert, Karine Renaudin, Richard Danger, Florent Le Borgne, Clarisse Kerleau, Gaelle Tilly, Anais Vivet, Florent Delbos, Alexandre Walencik, Magali Giral, Sophie Brouard

Summary: The study found that the percentage and absolute number of CD28-CD8+ T cells were significantly increased in kidney transplant patients with antibody-mediated rejection (ABMR). Moreover, CD28-CD8+ T cells from patients with ABMR showed a more rigorous response to stimulation compared to their CD28+ counterparts. These findings suggest that differentiated CD28-CD8+ T cells, with increased frequency, number, and function, may play a role in the pathobiology of ABMR.

EBIOMEDICINE (2022)

Article Immunology

Kidney allograft rejection is associated with an imbalance of B cells, regulatory T cells and differentiated CD28-CD8+T cells: analysis of a cohort of 1095 graft biopsies

Hoa Le Mai, Nicolas Degauque, Marine Lorent, Marie Rimbert, Karine Renaudin, Richard Danger, Clarisse Kerleau, Gaelle Tilly, Anais Vivet, Sabine Le Bot, Florent Delbos, Alexandre Walencik, Magali Giral, Sophie Brouard

Summary: This study found that kidney allograft rejection is associated with an imbalance between immune cells with effector/memory functions and those with regulatory properties, manifested as a decrease in the percentage of circulating B cells and an increase in the ratio of CD28-CD8+ T cells to Tregs.

FRONTIERS IN IMMUNOLOGY (2023)

Review Immunology

Regulation of CD8 T cell by B-cells: A narrative review

Tess Van Meerhaeghe, Antoine Neel, Sophie Brouard, Nicolas Degauque

Summary: The role of B cells in the regulation of CD8 T cell survival, proliferation, and memory formation has been a topic of debate. B cells can act as antigen-presenting cells for CD8 T cells due to their high expression of MHC class I molecules. In various conditions, such as viral infections, autoimmune diseases, cancer, and allograft rejection, B cells have been shown to modulate CD8 T cell function. However, B-cell depletion therapies can impair CD8 T cell responses.

FRONTIERS IN IMMUNOLOGY (2023)

Meeting Abstract Surgery

Antibody-Mediated Allograft Rejection isAssociated with an Increase in Peripheral Differentiated CD28-CD8+T Cells - Analyses of a Cohort of 1032 Kidney Transplant Recipients.

H. L. Mai, N. Degauque, S. Le Bot, M. Rimbert, K. Renaudin, R. Danger, F. Le Borgne, C. Kerleau, F. Delbos, M. Giral, S. Brouard

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Meeting Abstract Surgery

TEMRA CD8 T CELLS FROM KIDNEY TRANSPLANT RECIPIENTS EXHIBIT ENHANCED PURINERGIC P2X4 RECEPTOR-DEPENDENT PROINFLAMMATORY AND MIGRATORY RESPONSES

Gaelle Tilly, Tra-My Doan-Ngoc, Orianne Bonizec, Christophe Masset, Richard Danger, Pierrick Guerif, Sarah Bruneau, Alexandre Glemain, Jean Harb, Magali Giral, Claire Pecqueur, Sophie Brouard, Nicolas Degauque

TRANSPLANT INTERNATIONAL (2021)

Meeting Abstract Surgery

ANTIBODY-MEDIATED REJECTION OF KIDNEY ALLOGRAFT IS ASSOCIATED WITH AN INCREASE IN DIFFERENTIATED CD28-CD8+T CELLS IN THE PERIPHERAL BLOOD

Hoa Mai, Sabine Le Bot, Marie Rimbert, Karine Autain-Renaudin, Richard Danger, Florent Leborgne, Clarisse Kerleau, Nicolas Degauque, Florent Delbos, Magali Giral, Sophie Brouard

TRANSPLANT INTERNATIONAL (2021)

暂无数据